HC Wainwright Cuts Aethlon Medical (NASDAQ:AEMD) Price Target to $7.00

Aethlon Medical (NASDAQ:AEMD) had its target price reduced by stock analysts at HC Wainwright from $10.00 to $7.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock.

Separately, StockNews.com initiated coverage on Aethlon Medical in a report on Sunday. They issued a “sell” rating for the company.

Aethlon Medical Stock Down 2.5 %

AEMD stock opened at $0.58 on Monday. The firm has a market cap of $1.53 million, a PE ratio of -0.12 and a beta of 1.60. The business has a 50 day moving average of $0.87 and a 200-day moving average of $1.48. Aethlon Medical has a 12-month low of $0.37 and a 12-month high of $5.00.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.